GoodRx (GDRX) CEO Wendy Barnes Exercises RSUs; Shares Withheld for Taxes

What Happened
Wendy Lynn Barnes, Chief Executive Officer and President of GoodRx (GDRX), converted/ exercised restricted stock units (RSUs) on July 15, 2026, resulting in the issuance of 277,288 shares. To satisfy tax withholding obligations, 120,456 of those shares were withheld (reported as dispositions) at $3.01 per share, totaling $362,572. The net shares delivered to Barnes were 156,832. Several derivative lines in the filing show $0 disposals reflecting the RSU conversion/cancellation on vesting.

Key Details

• Transaction date: July 15, 2026; filing date: July 16, 2026 (timely filing).
• Gross shares from conversion: 277,288 (115,148 + 51,177 + 110,963).
• Shares withheld for taxes (disposed): 120,456 (50,021 + 22,232 + 48,203) at $3.01/share = $362,572.
• Net shares issued to insider: 156,832.
• Transaction codes: M = exercise/conversion of derivative (RSU → shares); F = payment of tax liability via share withholding.
• Footnotes: RSUs represent contingent rights to one share each and have differing vesting schedules (see filing): some awards vest 25% on Jan 15, 2026 then quarterly over 12 quarters; others vest 50% on Jan 15, 2026 with remaining vesting quarterly over 4 quarters; some vest ratably in 12 quarterly installments beginning Apr 15, 2026.
• Shares owned after the transaction: not specified in the provided data.

Context
This filing reflects vested RSUs converting into common stock with shares withheld to cover tax obligations — a common, routine administrative transaction (cashless tax withholding), not an open-market sale signaling a directional trade. The filing does not indicate a 10% owner, a 10b5‑1 plan, or other unusual arrangements.